Latest Medicxi Ventures Management (Jersey) Ltd Stock Portfolio
Medicxi Ventures Management (Jersey) Ltd Performance:
2025 Q3: 56.08%YTD: 27.47%2024: 74.66%
Performance for 2025 Q3 is 56.08%, and YTD is 27.47%, and 2024 is 74.66%.
About Medicxi Ventures Management (Jersey) Ltd and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Medicxi Ventures Management (Jersey) Ltd reported an equity portfolio of $744.4 Millions as of 30 Sep, 2025.
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, PHAT, NAMS. The fund has invested 65% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 11.8% of portfolio in PHATHOM PHARMACEUTICALS INC .
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT) stocks. Medicxi Ventures Management (Jersey) Ltd opened new stock positions in RAPT THERAPEUTICS INC (RAPT).
The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, PHAT, NAMS. The fund has invested 65% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 11.8% of portfolio in PHATHOM PHARMACEUTICALS INC .
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT) stocks. Medicxi Ventures Management (Jersey) Ltd opened new stock positions in RAPT THERAPEUTICS INC (RAPT).
Medicxi Ventures Management (Jersey) Ltd Annual Return Estimates Vs S&P 500
Our best estimate is that Medicxi Ventures Management (Jersey) Ltd made a return of 56.08% in the last quarter. In trailing 12 months, it's portfolio return was 19.53%.
New Buys
| Ticker | $ Bought |
|---|---|
| rapt therapeutics inc | 72,057,300 |
New stocks bought by Medicxi Ventures Management (Jersey) Ltd
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| rapt therapeutics inc | -22,352,000 |
Medicxi Ventures Management (Jersey) Ltd got rid off the above stocks
Sector Distribution
Medicxi Ventures Management (Jersey) Ltd has about 100% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 100 |
Market Cap. Distribution
Medicxi Ventures Management (Jersey) Ltd has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 79.4 |
| UNALLOCATED | 11 |
| MICRO-CAP | 9.7 |
Stocks belong to which Index?
About 24% of the stocks held by Medicxi Ventures Management (Jersey) Ltd either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 76 |
| RUSSELL 2000 | 24 |
Medicxi Ventures Management (Jersey) Ltd Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Medicxi Ventures Management (Jersey) Ltd
Medicxi Ventures Management (Jersey) Ltd has 5 stocks in it's portfolio. AURA proved to be the most loss making stock for the portfolio. CNTA was the most profitable stock for Medicxi Ventures Management (Jersey) Ltd last quarter.
Last Reported on: 17 Oct, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AURA | aura biosciences inc | 2.52 | 3,039,890 | 18,786,500 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 65.03 | 19,963,200 | 484,107,000 | unchanged | 0.00 | ||
| NAMS | newamsterdam pharma company | 10.96 | 2,869,560 | 81,610,400 | unchanged | 0.00 | ||
| PHAT | phathom pharmaceuticals inc | 11.80 | 7,464,570 | 87,858,000 | unchanged | 0.00 | ||
| RAPT | rapt therapeutics inc | 9.68 | 2,794,000 | 72,057,300 | new | |||
| RAPT | rapt therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||